Research Article

Differential Regulation of MicroRNAs in End-Stage Failing Hearts Is Associated with Left Ventricular Assist Device Unloading

Table 1

Patient characteristics and clinical parameters.

HTx-CTRL ()HTx-LVAD ()
Pre-LVADPost-LVAD

Age (years), mean ± SE52 ± 346 ± 4
Male gender ()58
Duration of LVAD assistance (days), mean ± SE357 ± 66
Ischemic heart disease (IHD) ()21

Cardiac index (L/min/m2), mean ± SE1.90 ± 0.171.61 ± 0.13
PCWP (mm Hg), mean ± SE14 ± 324 ± 59 ± 3
PASP (mm Hg), mean ± SE33 ± 447 ± 627 ± 3
PADP (mm Hg), mean ± SE13 ± 212 ± 4
LVEF (%), mean ± SE26 ± 221 ± 228 ± 3
LVESV (mL), mean ± SE 147 ± 17160 ± 20
LVEDV (mL), mean ± SE196 ± 18219 ± 18
LVEDD (mm), mean ± SE66 ± 270 ± 3
NT-proBNP (ng/L), mean ± SE2976 ± 15624800 ± 991576 ± 145

versus HTx-CTRL; versus HTx-CTRL; versus HTx-CTRL; versus pre-LVAD; versus pre-LVAD.
PCWP: pulmonary capillary wedge pressure; PASP: pulmonary artery systolic pressure; PADP: pulmonary artery diastolic pressure; LVEF: left ventricular ejection fraction; LVESV: left ventricular end-systolic volume; LVEDV: left ventricular end-diastolic volume; LVEDD: left ventricular end-diastolic diameter; NT-proBNP: N-terminal prohormone of brain natriuretic peptide.